Valuation: Lead Data Inc.

Market Cap 539M 16.86M 14.74M 13.54M 12.62M 23.94M 1.61B 24.31M 163M 63.21M 789M 63.28M 61.92M 2.72B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.77M 15.53M 14.28M 13.31M 25.24M 1.69B 25.62M 171M 66.62M 832M 66.7M 65.26M 2.87B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 2022-08-16
Director of Finance/CFO - 2022-06-09
Corporate Officer/Principal - 2022-06-09
Director TitleAgeSince
Director/Board Member - 2019-06-09
Chairman - 2022-08-16
Director/Board Member - 2022-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+2.00% 16.86M
+2.26%+1.74%+15.75%+8.81% 9.85B
+1.73%+5.69% - - 1.31B
+1.71%+4.94%+16.01%-0.67% 1.29B
+0.82%+3.05%-0.72%-11.62% 1.03B
-1.12%+6.30%+66.62%+38.31% 673M
+1.68%+4.30%-19.98% - 584M
-1.61%0.00%+108.98%+163.06% 419M
+0.72%+1.16%-13.12%-18.90% 410M
+0.28%+7.49%-61.02%-79.87% 275M
Average -0.34%+1.48%+12.50%+12.64% 1.59B
Weighted average by Cap. +1.72%+3.56%+15.93%+9.92%

Financials

2024 2025
Net sales 15.47M 484K 423K 389K 362K 687K 46.08M 698K 4.67M 1.81M 22.65M 1.82M 1.78M 78.05M 111M 3.46M 3.03M 2.78M 2.59M 4.92M 330M 4.99M 33.4M 12.99M 162M 13M 12.72M 559M
Net income -134M -4.19M -3.66M -3.36M -3.13M -5.95M -399M -6.04M -40.38M -15.7M -196M -15.71M -15.38M -675M -44.02M -1.38M -1.2M -1.11M -1.03M -1.96M -131M -1.99M -13.28M -5.16M -64.46M -5.17M -5.06M -222M
Net Debt -16.95M -530K -464K -426K -397K -753K -50.51M -765K -5.12M -1.99M -24.83M -1.99M -1.95M -85.55M 29.12M 911K 797K 732K 682K 1.29M 86.75M 1.31M 8.79M 3.42M 42.64M 3.42M 3.35M 147M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock